Tilray Brands, Inc. Capital Expenditures
Tilray Brands, Inc. (TLRY) reported Capital Expenditures of $2.47 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2021-05-10
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for the quarter ending 2021-03-31 was $2.47M, a 86.52% decline year-over-year.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $5.28M, a 77.37% decline year-over-year.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $11.87M, a 50.85% decline year-over-year.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $9.20M, a 46.64% decline year-over-year.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $44.64M, a 39.46% decline from fiscal 2019.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $73.74M, a 46.90% increase from fiscal 2018.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $50.20M, a 360.11% increase from fiscal 2017.
- Tilray Brands, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $10.91M, a 2135.66% increase from fiscal 2016.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2021-03-31 | $2.47M 10-Q · filed 2021-05-10 | $7.74M derived: sum of 2 quarters · filed 2021-05-10 | $19.62M derived: sum of 3 quarters · filed 2021-05-10 | $28.82M derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $17.15M derived: sum of 2 quarters · filed 2021-02-19 | $26.35M derived: sum of 3 quarters · filed 2021-02-19 | $44.64M 10-K · filed 2021-02-19 |
| 2020-09-30 | $11.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $21.08M derived: sum of 2 quarters · filed 2020-11-09 | $39.37M 10-Q · filed 2020-11-09 | $62.69M derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-06-30 | $9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $27.49M 10-Q · filed 2020-08-10 | $50.81M derived: sum of 3 quarters · filed 2021-05-10 | $74.97M derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-03-31 | $18.29M 10-Q · filed 2021-05-10 | $41.61M derived: sum of 2 quarters · filed 2021-05-10 | $65.77M derived: sum of 3 quarters · filed 2021-05-10 | $83.01M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $23.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $47.48M derived: sum of 2 quarters · filed 2021-02-19 | $64.72M derived: sum of 3 quarters · filed 2021-02-19 | $73.74M 10-K · filed 2021-02-19 |
| 2019-09-30 | $24.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $41.40M derived: sum of 2 quarters · filed 2020-11-09 | $50.42M 10-Q · filed 2020-11-09 | $62.54M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $17.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $26.26M 10-Q · filed 2020-08-10 | $38.38M derived: sum of 3 quarters · filed 2021-02-19 | $48.22M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $9.02M 10-Q · filed 2020-05-11 | $21.14M derived: sum of 2 quarters · filed 2021-02-19 | $30.98M derived: sum of 3 quarters · filed 2021-02-19 | $46.36M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $21.96M derived: sum of 2 quarters · filed 2021-02-19 | $37.34M derived: sum of 3 quarters · filed 2021-02-19 | $50.20M 10-K · filed 2021-02-19 |
| 2018-09-30 | $9.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $25.22M derived: sum of 2 quarters · filed 2019-11-13 | $38.08M 10-Q · filed 2019-11-13 | $45.69M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $15.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $28.24M 10-Q · filed 2019-08-13 | $35.85M derived: sum of 3 quarters · filed 2020-03-02 | $38.31M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $12.86M 10-Q · filed 2019-05-15 | $20.47M derived: sum of 2 quarters · filed 2020-03-02 | $22.93M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $10.07M derived: sum of 2 quarters · filed 2020-03-02 | $10.91M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $3.30M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $835.00K 10-Q · filed 2018-08-29 | |||
| 2016-12-31 | $488.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |